Although radiogenomics has the capacity to alter how patients with brain tumors are managed in the future, additional tumor characteristics from advanced MRI, such as cellularity and angiogenesis, should be pursued to improve the noninvasive diagnostic performance of MGMT methylation. Here, MGMT is linked to brain neoplasm.